Structure-activity relationships of middle-size cyclic peptides, KRAS inhibitors derived from an mRNA display.

RPEP-085102024Kage, Mirai; Hayashi, Ryuji; Matsuo, Atsushi; Tamiya, Minoru; Kuramoto, Shino; Ohara, Kazuhiro; Irie, Machiko; Chiyoda, Aya; Takano, Koji; Ito, Toshiya; Kotake, Tomoya; Takeyama, Ryuuichi; Ishikawa, Shiho; Nomura, Kenichi; Furuichi, Noriyuki; Morita, Yuya; Hashimoto, Satoshi; Kawada, Hatsuo; Nishimura, Yoshikazu; Nii, Keiji; Sase, Hitoshi; Ohta, Atsushi; Kojima, Tetsuo; Iikura, Hitoshi; Tanada, Mikimasa; Shiraishi, Takuya

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Structure-activity relationships of middle-size cyclic peptides, KRAS inhibitors derived from an mRNA display.

Bioorganic & medicinal chemistry, 110, 117830

View on PubMed ↗Publisher’s paper ↗

Citation

Kage, Mirai; Hayashi, Ryuji; Matsuo, Atsushi; Tamiya, Minoru; Kuramoto, Shino; Ohara, Kazuhiro; Irie, Machiko; Chiyoda, Aya; Takano, Koji; Ito, Toshiya; Kotake, Tomoya; Takeyama, Ryuuichi; Ishikawa, Shiho; Nomura, Kenichi; Furuichi, Noriyuki; Morita, Yuya; Hashimoto, Satoshi; Kawada, Hatsuo; Nishimura, Yoshikazu; Nii, Keiji; Sase, Hitoshi; Ohta, Atsushi; Kojima, Tetsuo; Iikura, Hitoshi; Tanada, Mikimasa; Shiraishi, Takuya. (2024). Structure-activity relationships of middle-size cyclic peptides, KRAS inhibitors derived from an mRNA display.. Bioorganic & medicinal chemistry, 110, 117830. https://doi.org/10.1016/j.bmc.2024.117830